Skip Navigation
American College of Physicians Logo
  • Subscribe
  • Submit a Manuscript
  •  Free Account
  • Sign In
Annals of Internal Medicine Logo Menu
  • Latest
  • Issues
  • Channels
  • CME/MOC
  • In the Clinic
  • Journal Club
  • Web Exclusives
  • Author Info
Advanced Search
  • ‹ PREV ARTICLE
  • This Issue
  • NEXT ARTICLE ›
Position Papers |15 January 1994

Recommended Guidelines for the Management of Autologous and Allogeneic Bone Marrow Transplantation: A Report from the Eastern Cooperative Oncology Group (ECOG)

Jacob M. Rowe, MD; Niculae Ciobanu, MD; Joao Ascensao, MD, PhD; Edward A. Stadtmauer, MD; Roy S. Weiner, MD; David P. Schenkein, MD; Philip McGlave, MD; Hillard M. Lazarus, MD; Eastern Cooperative Oncology Group.

Jacob M. Rowe, MD

Niculae Ciobanu, MD

Joao Ascensao, MD, PhD

Edward A. Stadtmauer, MD

Roy S. Weiner, MD

David P. Schenkein, MD

Philip McGlave, MD

Hillard M. Lazarus, MD

Eastern Cooperative Oncology Group.

Article, Author, and Disclosure Information
Author, Article, and Disclosure Information
Copyright ©2004 by the American College of Physicians
2004
  • From the Eastern Oncology Cooperative Group, Denver, Colorado. Requests for Reprints: Hillard M. Lazarus, MD, Department of Medicine, University Hospitals of Cleveland, 2074 Abington Road, Cleveland, OH 44106. Acknowledgments: The authors thank Karen Balta and Kim Pringle for preparation of the manuscript. Grant Support: In part by Public Health Service grants CA21115, CA14548, and P30CA43703 from the National Institutes of Health, the National Cancer Institute, and the Department of Health and Human Services.
×
  • ‹ PREV ARTICLE
  • This Issue
  • NEXT ARTICLE ›
Jump To
  • Full Article
  • Figures
  • Tables
  • Supplements
  • Audio/Video
  • Summary for Patients
  • Clinical Slide Sets
  • CME / MOC
  • Comments
  • Twitter Link
  • Facebook Link
  • Email Link
More
  • LinkedIn Link
  • CiteULike Link

The full content of Annals is available to subscribers

Subscribe/Learn More

Abstract

Objective:

To define the basic state-of-the-art medical care of the patients after bone marrow transplantation as practiced by the Eastern Cooperative Oncology Group.

Data Identification:

Studies examining the role of bone marrow transplantation in the care of neoplastic disorders identified using computer and bibliographic searches.

Study Selection:

More than 500 articles, book chapters, and abstracts from meetings, covering all therapeutic and diagnostic aspects of the patient having bone marrow transplantation were critically reviewed; information from over 200 publications is included.

Results of Data Analysis:

Enormous progress has been made in understanding the biology, therapy, and prophylaxis strategies of bone marrow transplantation and in extending the range of potential marrow donors to include unrelated persons. Dramatic advances have occurred in the prevention of serious infection, including cytomegalovirus infection, formerly a cause of a high rate of mortality. The advent of newer-combination, high-dose chemotherapy regimens and advances in cryopreservation and in vitro marrow purging techniques have led to increased use and greater efficacy of autologous transplantation. Recent advances using recombinant hematopoietic growth factors and autologous peripheral stem cells are likely to reduce morbidity and mortality and significantly shorten the length of hospitalization and the cost of bone marrow transplantation.

Conclusions:

Bone marrow transplantation now is a common procedure done throughout the world. Cooperative groups have assumed a major role in conducting clinical trials. A standardized approach defining basic standards of care will assure uniformity of management, better interpretation of data, and continued progress in the care of the patient who has had a bone marrow transplantation. Basic research and clinical trials are ongoing to define better methods for the treatment and prevention of graft-versus-host disease and hepatic veno-occlusive disease.

This feature is available only to Registered Users

Subscribe/Learn More

Sign In

  • Sign in as individual >
  • Sign in as institution >
  • Forgot your password?
Buy Article Now

Want to Subscribe?

Learn more about subscription options.

Register Now for a free account.

PDF
Not Available
Citations
Citation

Rowe JM, Ciobanu N, Ascensao J, Stadtmauer EA, Weiner RS, Schenkein DP, et al. Recommended Guidelines for the Management of Autologous and Allogeneic Bone Marrow Transplantation: A Report from the Eastern Cooperative Oncology Group (ECOG). Ann Intern Med. 1994;120:143-158. doi: 10.7326/0003-4819-120-2-199401150-00008

Download citation file:

  • RIS (Zotero)
  • EndNote
  • BibTex
  • Medlars
  • ProCite
  • RefWorks
  • Reference Manager

© 2017

×
Permissions

Published: Ann Intern Med. 1994;120(2):143-158.

DOI: 10.7326/0003-4819-120-2-199401150-00008

219 Views since 1/1/2013
0 Citations
Advertisement

Related Articles

Allogeneic Bone Marrow Transplantation for Chronic Myeloid Leukemia Using Sibling and Volunteer Unrelated Donors: A Comparison of Complications in the First 2 Years
Annals of Internal Medicine; 119 (3): 207-214
Health and Functional Status of Long-Term Survivors of Bone Marrow Transplantation
Annals of Internal Medicine; 126 (3): 184-192
Ganciclovir Prophylaxis of Cytomegalovirus Infection and Disease in Allogeneic Bone Marrow Transplant Recipients: Results of a Placebo-Controlled, Double-Blind Trial
Annals of Internal Medicine; 118 (3): 179-184
Unrelated Donor Bone Marrow Transplantation for Chronic Myelogenous Leukemia: A Decision Analysis
Annals of Internal Medicine; 127 (12): 1080-1088
View MoreView Less

Related Topics

Hematology/Oncology
Infectious Disease
Neurology
Prevention/Screening

Hematology/Oncology, Infectious Disease, Neurology, Prevention/Screening.

PubMed Articles

SAV1 represses the development of human colorectal cancer by regulating the Akt-mTOR pathway in a YAP-dependent manner.
Cell Prolif 2017.
Renoprotective Effect of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Diabetic Patients with Proteinuria.
Kidney Blood Press Res 2017;
View More

Results provided by: PubMed

Advertisement
link to top

Content

  • Home
  • Latest
  • Issues
  • Channels
  • CME/MOC
  • In the Clinic
  • Journal Club
  • Web Exclusives

Information For

  • Author Info
  • Reviewers
  • Press
  • Readers
  • Institutions / Libraries / Agencies
  • Advertisers

Services

  • Subscribe
  • Renew
  • Alerts
  • Current Issue RSS
  • Online First RSS
  • In the Clinic RSS
  • Reprints & Permissions
  • Contact Us
  • Help
  • About Annals
  • About Mobile
  • Patient Information
  • Teaching Tools
  • Annals in the News
  • Share Your Feedback

Awards

  • Personae Photography Prize
  • Junior Investigator Awards
  • Poetry Prize

Other Resources

  • ACP Online
  • Career Connection
  • ACP Advocate Blog
  • ACP Journal Wise

Follow Annals On

  • Twitter Link
  • Facebook Link
acp link acp
silverchair link silverchair

Copyright © 2017 American College of Physicians. All Rights Reserved.

Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Privacy Policy

|

Conditions of Use

×

You need a subscription to this content to use this feature.

×

This PDF is available to Subscribers Only

Sign In

  • Sign in as individual >
  • Sign in as institution >
  • Forgot your password?